Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
As of early 2026, retatrutide is not FDA approved and cannot be legally prescribed or purchased
GLP-1 receptor agonists are currently approved for treating type 2 diabetes and, in some cases, obesity
The coverage gap exacerbates health inequities: obesity disproportionately affects lower-income and minority populations who rely on public insurance
Applicable Procedure Codes: J2323, Q5134
US$ 22.12
US$ 21.05
US$ 29.77
